Sales of its GLP-1s Mounjaro and Zepbound bumped Q3 2025 revenue 54% YoY to $17.6 billion, the company shared on Oct
Rankings reflect community discussion patterns among Reddit users, which are not representative of all GLP-1 users
Inositol is considered very safe, with few reported side effects
These risks are similar to injectable GLP-1 medications, and patients should consult with their provider before use
A separate 2026 modeling study, built from randomized trial data, estimated that people regained about 60 percent of their lost weight by one year after discontinuation, with regain slowing later and potentially leveling off short of a full return to baseline
weekly injectable dosing As well as associated conditions which may synergize with the issues GLP-1s present